BioSpace News Archive

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

Are you passionate about research, business, science and leadership? If so, you might be interested in a job as a principal investigator.

Let’s take a closer look at a few things that you should definitely do, as well as a couple that you shouldn’t, in order to make a good first impression.

Researchers with Pfizer and IBM developed an artificial intelligence (AI) model that they claim can predict eventual onset of Alzheimer’s disease with 71% accuracy based on a language sample. They published the research today in The Lancet eClinicalMedicine.

NANTES, France, Oct. 22, 2020 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) today announced a publication in the prestigious Journal of Clinical Investigation (JCI) of translational and preclinical study data in rodent in vivo and human ex vivo models characterizing the efficacy and mechanism of action of BI 765063, formerly OSE-172, the first selective antibody antagonist of SIRPα-mediated “Don’t Eat Me” signals. Importantly, for the first time ever the

Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), hereafter “Onxeo” or “the Company”, a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage response (DDR), in particular against rare or resistant cancers, today announced that it has received from the European Patent Office (EPO) a notice of intent to grant a patent which strengthens the protection in Europe of AsiDNA

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

Fresenius Medical Care North America (FMCNA), the nation’s leading provider of kidney care products and services, today announced the presentation of 65 company-affiliated abstracts at the American Society of Nephrology (ASN) Annual Conference Kidney Week 2020 Reimagined, which runs virtually from Oct. 22-25, 2020

Spartan Medical Inc. announced the launch of a Comprehensive COVID-19 Testing Solution to assist the Department of Veterans Affairs with their protocolized clearance and improved workflow for patient procedures.

The new fund will help Volunteers of America sustainably scale Family Focused Recovery program operations to provide comprehensive services to mothers with substance use disorder and their children